| PMOs | periodic mesoporous organosilicas |
| BPMOs | biodegradable periodic mesoporous organosilica nanoparticles |
| EPR | enhanced permeability and retention |
| MSNs | Mesoporous silica nanoparticles |
| CTAB | cetyltrimethylammonium bromide |
| TEOS | tetraalkoxysilane |
| HD | hydrodynamic diameter |
| GSH | glutathione |
| EDIS | Ethylene-Bis(Propyl) Disulfide |
| MPMO | Mixed PMO |
| DOX | Doxorubicin |
| CAM | Chick Chorioallantoic Membrane |
| PBS | Phosphate-buffered saline |
| SBF | simulated body fluid |
| DNR | Daunorubicin |
| TEM | transmission electron microscope |
| BTESPT | bis-(triethoxysilylpropyl)tetrasulfide |
| PCMONSs | Mesoporous Organosilica Nanosheets |
| HMONs | hollow mesoporous organosilica nanocapsule |
| ICP | Inductively coupled plasma |
| Cys-PMO | cystamine-integrated periodic mesoporous organosilica |
| PTX | Paclitaxel |
| His-PMO | histidine-periodic mesoporous organosilicas |
| NC | nanocomposite |
| SAMs | self-assembled monolayers |
| SDU–HMS | safranin–diurea bridged hybrid mesoporous organosilica |
| 5-FU | 5-fluorouracil |
| AZO-B | Azobenzene linkers were condensed with aromatic benzene (B) |
| AZO-E | Azobenzene linkers were condensed with aliphatic ethane (E) |
| NIRF | near-infrared fluorescence |
| CuS | Copper monosulfide |
| DMPy-PMO | Disilylated 2,6-Dimethylpyridine-PMO |
| GMP | gemcitabine monophosphate |
| PEG | polyethylene glycol |
| MoS2 | Molybdenum disulfide |
| FRET | fluorescence resonance energy transfer |
| PDT | photodynamic therapy |
| HPMOs | hybrid hollow PMOs |
| HIFU | high intensity focused ultrasound |
| MPMS | 3-mercaptopropyltrimethoxysilane |
| MPDMS | 3-mercaptopropyl(dimethoxy)methylsilane |
| NMR | Nuclear magnetic resonance |